Betulinic acid reduces ultraviolet-C-induced DNA breakage in congenital melanocytic naeval cells: evidence for a potential role as a chemopreventive agent
- 1 April 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Melanoma Research
- Vol. 11 (2) , 99-104
- https://doi.org/10.1097/00008390-200104000-00003
Abstract
Melanoma transformation progresses in a multistep fashion from precursor lesions such as congenital naevi. Exposure to ultraviolet (UV) light promotes this process. Betulinic acid (BA) was identified by our group as a selective inhibitor of melanoma that functions by inducing apoptosis. The present study was designed to investigate the effect of BA and UV-C (254 nm) on cultured congenital melanocytic naevi (CMN) cells, using the single-cell gel electrophoresis (comet) assay to detect DNA damage. Exposure to UV light induced a 1.7-fold increase in CMN cells (P = 0.008) when compared with controls. When a p53 genetic suppressor element that encodes a dominant negative polypeptide (termed GSE56) was introduced into the CMN cells, the transfected cells were more sensitive to UV-induced DNA breakage. This suggests that p53 can protect against UV-induced DNA damage and subsequent melanoma transformation. Pretreatment with BA (3 μm) for 48 h resulted in a 25.5% reduction in UV-induced DNA breakage in the CMN cells (P = 0.023), but no changes were observed in the transfected cells. However, Western blot analysis revealed no changes in the p53 or p21 levels in BA-treated cells, suggesting that BA might mediate its action via a non-p53 pathway. These data indicate that BA may have an application as a chemopreventive agent in patients with congenital naevi.Keywords
This publication has 28 references indexed in Scilit:
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- The Pathogenesis of Melanoma Induced by Ultraviolet RadiationNew England Journal of Medicine, 1999
- Recovery of the normal p53 response after UV treatment in DNA repair- deficient fibroblasts by retroviral-mediated correction with the XPD geneCarcinogenesis: Integrative Cancer Research, 1998
- p53-mediated transcription induces resistance of DNA to UV inactivationOncogene, 1998
- The comet assay: A new method to examine heterogeneity associated with solid tumorsNature Medicine, 1998
- Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains.Proceedings of the National Academy of Sciences, 1996
- Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosisNature Medicine, 1995
- Cell Cycle Control and CancerScience, 1994
- Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA.Proceedings of the National Academy of Sciences, 1993
- Human Melanocytic Neoplasms and Their Etiologic Relationship with Sunlight.Journal of Investigative Dermatology, 1989